Stoke Therapeutics, Inc. (STOK) Depreciation USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Stoke Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2024.
  • Stoke Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $563 K, a 5.7% decline year-over-year.
  • Stoke Therapeutics, Inc. annual Depreciation for 2023 was $2.47 M, a 59.7% increase from 2022.
  • Stoke Therapeutics, Inc. annual Depreciation for 2022 was $1.55 M, a 58.7% increase from 2021.
  • Stoke Therapeutics, Inc. annual Depreciation for 2021 was $974 K, a 9.69% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $563 K -$34 K -5.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q1 2023 $597 K +$350 K +142% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q1 2022 $247 K +$11 K +4.66% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $236 K +$43 K +22.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $193 K +$113 K +141% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $80 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.